Scleral-fixated posterior chamber intraocular lens implantation in pediatric and adult patients.
To evaluate the results of scleral-fixated posterior chamber intraocular lenses (SFIOL) in pediatric and adult patients. We carried out a retrospective analysis of 129 eyes of 120 patients (adult group, n = 96; pediatric group, n = 24) who underwent SFIOL implantation. Outcome measures were indications, corrected distance visual acuity (CDVA), change in visual acuity, and complications. The median follow-up time was six months (minimum: 6; maximum: 55 months). The median preoperative CDVAs were similar between the groups (p = 0,253). The median postoperative CDVA was 0.2 (min: hand motion; max: 0.8) in pediatric patients and 0.5 (min: hand motion; max: 1.0) in adult patients in decimal notation, (p = 0.017). The CDVA improved at least one Snellen line or remained unchanged in all pediatric eyes, and in 87 (90.6%) adult eyes. The change in visual acuity was similar between the groups (p = 0.296). In both pediatric and adult patients, SFIOL implantation ends with favorable outcomes over the short term.